|
OMIM |
Link |
Information gain |
01 |
|
MAFD6
|
[NCBI]
|
0.00335641
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.0024079
|
|
|
PSORS5
|
[NCBI]
|
0.00229823
|
|
|
OFC1
|
[NCBI]
|
0.00200522
|
|
|
autism
|
[NCBI]
|
0.00177706
|
|
|
OFC3
|
[NCBI]
|
0.00166142
|
|
|
SCZD7
|
[NCBI]
|
0.00122318
|
|
|
CRCS2
|
[NCBI]
|
0.00116898
|
|
|
CHDS8
|
[NCBI]
|
0.00116898
|
|
|
PARK3
|
[NCBI]
|
0.00115396
|
|
|
IBD5
|
[NCBI]
|
0.00109301
|
|
|
AUTS6
|
[NCBI]
|
0.00109301
|
|
|
DYX3
|
[NCBI]
|
0.00100737
|
|
|
AUTS5
|
[NCBI]
|
0.000897535
|
|
|
AD14
|
[NCBI]
|
0.000897535
|
|
|
AD13
|
[NCBI]
|
0.000897535
|
|
|
IGAD1
|
[NCBI]
|
0.000866377
|
|
|
IOSCA
|
[NCBI]
|
0.000814184
|
|
|
FEB6
|
[NCBI]
|
0.000764714
|
|
|
HSCR8
|
[NCBI]
|
0.000764714
|
|
|
BMND7
|
[NCBI]
|
0.000764714
|
|
|
generalized epilepsy with febrile seizures plus, type 4
|
[NCBI]
|
0.000764714
|
|
|
glioma, familial, 1
|
[NCBI]
|
0.000764714
|
|
|
MAFD1
|
[NCBI]
|
0.000762677
|
|
|
AUTS9
|
[NCBI]
|
0.00069119
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.00069119
|
|
|
SLI3
|
[NCBI]
|
0.000503031
|
|
|
rosselli-gulienetti syndrome
|
[NCBI]
|
0.000503031
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.000503031
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.000503031
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.000503031
|
|
|
IBD7
|
[NCBI]
|
0.000503031
|
|
|
alzheimer disease 7
|
[NCBI]
|
0.000503031
|
|
|
IDDM6
|
[NCBI]
|
0.000503031
|
|
|
IDDM4
|
[NCBI]
|
0.000501652
|
|
|
SCZD
|
[NCBI]
|
0.000495748
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000474474
|
|
|
IDDM
|
[NCBI]
|
0.000449255
|
|
|
MS
|
[NCBI]
|
0.000415618
|
|
|
myasthenia gravis with thymus hyperplasia
|
[NCBI]
|
0.000406461
|
|
|
PSORS3
|
[NCBI]
|
0.000406461
|
|
|
neuropathy, hereditary motor and sensory, okinawa type
|
[NCBI]
|
0.000406461
|
|
|
AUTS10
|
[NCBI]
|
0.000406461
|
|
|
HSCR9
|
[NCBI]
|
0.000406461
|
|
|
OFC2
|
[NCBI]
|
0.000406461
|
|
|
PARK10
|
[NCBI]
|
0.000406461
|
|
|
IDDM18
|
[NCBI]
|
0.000406461
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000367354
|
|
|
SCZD3
|
[NCBI]
|
0.000367354
|
|
|
DYX2
|
[NCBI]
|
0.000360842
|
|
|
restless legs syndrome, susceptibility to, 6
|
[NCBI]
|
0.000344988
|
|
|
CELIAC6
|
[NCBI]
|
0.000344988
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000344988
|
|
|
CMT2B2
|
[NCBI]
|
0.000344988
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000344988
|
|
|
DSMA3
|
[NCBI]
|
0.000344988
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
0.000344988
|
|
|
SCZD5
|
[NCBI]
|
0.000344988
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000300184
|
|
|
DYT7
|
[NCBI]
|
0.000300184
|
|
|
ETM2
|
[NCBI]
|
0.000300184
|
|
|
lethal congenital contracture syndrome 1
|
[NCBI]
|
0.000300184
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000300184
|
|
|
neural tube defects
|
[NCBI]
|
0.000292265
|
|
|
HSCR1
|
[NCBI]
|
0.000281962
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.000265199
|
|
|
ATOD6
|
[NCBI]
|
0.000265199
|
|
|
UFS
|
[NCBI]
|
0.000265199
|
|
|
SCZD10
|
[NCBI]
|
0.000265199
|
|
|
NIDDM2
|
[NCBI]
|
0.000265199
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000243771
|
|
|
BMND3
|
[NCBI]
|
0.0002367
|
|
|
PSORS4
|
[NCBI]
|
0.0002367
|
|
|
CLN5
|
[NCBI]
|
0.000234925
|
|
|
IBD1
|
[NCBI]
|
0.000231211
|
|
|
EGF
|
[NCBI]
|
0.000229056
|
|
|
obesity
|
[NCBI]
|
0.00022213
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000212813
|
|
|
IDDM7
|
[NCBI]
|
0.000212813
|
|
|
IS1
|
[NCBI]
|
0.000208033
|
|
|
orofacial cleft 6
|
[NCBI]
|
0.000193264
|
|
|
IGES
|
[NCBI]
|
0.000192374
|
|
|
IBD2
|
[NCBI]
|
0.000192374
|
|
|
SCZD6
|
[NCBI]
|
0.000192374
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000190104
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000183575
|
|
|
MJD
|
[NCBI]
|
0.0001765
|
|
|
HPCX
|
[NCBI]
|
0.000174611
|
|
|
PSORS1
|
[NCBI]
|
0.000170898
|
|
|
osteoarthritis
|
[NCBI]
|
0.000166571
|
|
|
CF
|
[NCBI]
|
0.000160247
|
|
|
COMT
|
[NCBI]
|
0.000156892
|
|
|
TCF7L2
|
[NCBI]
|
0.000155775
|
|
|
USH3
|
[NCBI]
|
0.000150863
|
|
|
NRG1
|
[NCBI]
|
0.000147673
|
|
|
ARMD4
|
[NCBI]
|
0.000145986
|
|
|
NIDDM
|
[NCBI]
|
0.000145889
|
|
|
PSORS2
|
[NCBI]
|
0.000145108
|
|
|
orofacial cleft 5
|
[NCBI]
|
0.000138039
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
0.000135958
|
|
|
DTNBP1
|
[NCBI]
|
0.000133102
|
|
|
IDE
|
[NCBI]
|
0.000132373
|
|
|
HSAN3
|
[NCBI]
|
0.000128151
|
|
|
AGT
|
[NCBI]
|
0.000126598
|
|
|
IDDM10
|
[NCBI]
|
0.000126331
|
|
|
CFH
|
[NCBI]
|
0.000122961
|
|
|
APOA5
|
[NCBI]
|
0.000122062
|
|
|
MYP2
|
[NCBI]
|
0.000121495
|
|
|
FCMD
|
[NCBI]
|
0.000114817
|
|
|
NGFB
|
[NCBI]
|
0.000113778
|
|
|
PAND1
|
[NCBI]
|
0.000111359
|
|
|
MG
|
[NCBI]
|
0.000108865
|
|
|
AITD3
|
[NCBI]
|
0.000104103
|
|
|
OPLL
|
[NCBI]
|
0.000104103
|
|
|
GTS
|
[NCBI]
|
0.000102179
|
|
|
RET
|
[NCBI]
|
0.0001002
|
|
|
IL6R
|
[NCBI]
|
9.8374e-05
|
|
|
LTA
|
[NCBI]
|
9.70284e-05
|
|
|
coronary heart disease, susceptibility to, 7
|
[NCBI]
|
9.66148e-05
|
|
|
leukocyte nuclear appendages, hereditary prevalence of
|
[NCBI]
|
9.66148e-05
|
|
|
immunodeficiency due to defect in mapbp-interacting protein
|
[NCBI]
|
9.66148e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
9.43019e-05
|
|
|
PD
|
[NCBI]
|
9.31935e-05
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
9.02259e-05
|
|
|
kawasaki disease
|
[NCBI]
|
9.02259e-05
|
|
|
GVM
|
[NCBI]
|
9.02259e-05
|
|
|
gracile syndrome
|
[NCBI]
|
9.02259e-05
|
|
|
RA
|
[NCBI]
|
8.8062e-05
|
|
|
T
|
[NCBI]
|
8.78054e-05
|
|
|
MAPT
|
[NCBI]
|
8.64277e-05
|
|
|
IGAN1
|
[NCBI]
|
8.59938e-05
|
|
|
proteus syndrome
|
[NCBI]
|
8.59938e-05
|
|
|
NPY
|
[NCBI]
|
8.34558e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
8.32229e-05
|
|
|
TPH2
|
[NCBI]
|
8.09456e-05
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
8.01702e-05
|
|
|
SCZD9
|
[NCBI]
|
8.01702e-05
|
|
|
ZDHHC8
|
[NCBI]
|
7.79177e-05
|
|
|
g30 gene
|
[NCBI]
|
7.79177e-05
|
|
|
ELN
|
[NCBI]
|
7.71516e-05
|
|
|
IRF6
|
[NCBI]
|
7.56692e-05
|
|
|
ADIPOR1
|
[NCBI]
|
7.56692e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
7.47494e-05
|
|
|
g72 gene
|
[NCBI]
|
7.32196e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
7.28791e-05
|
|
|
DYT3
|
[NCBI]
|
7.23213e-05
|
|
|
NPHS1
|
[NCBI]
|
7.23213e-05
|
|
|
KLK3
|
[NCBI]
|
7.02912e-05
|
|
|
SIDDT
|
[NCBI]
|
6.90027e-05
|
|
|
SCA16
|
[NCBI]
|
6.90027e-05
|
|
|
IPD1
|
[NCBI]
|
6.90027e-05
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
6.90027e-05
|
|
|
STQTL9
|
[NCBI]
|
6.90027e-05
|
|
|
myocardial infarction, susceptibility to, 1
|
[NCBI]
|
6.90027e-05
|
|
|
PCNA
|
[NCBI]
|
6.75879e-05
|
|
|
SLC22A4
|
[NCBI]
|
6.65247e-05
|
|
|
USH3A
|
[NCBI]
|
6.65247e-05
|
|
|
ADHD
|
[NCBI]
|
6.63138e-05
|
|
|
AAA
|
[NCBI]
|
6.59123e-05
|
|
|
HYLS1
|
[NCBI]
|
6.5253e-05
|
|
|
SLC12A8
|
[NCBI]
|
6.5253e-05
|
|
|
PTH
|
[NCBI]
|
6.4059e-05
|
|
|
AVP
|
[NCBI]
|
6.39796e-05
|
|
|
FGF20
|
[NCBI]
|
6.39547e-05
|
|
|
HTR2A
|
[NCBI]
|
6.37141e-05
|
|
|
APC
|
[NCBI]
|
6.29262e-05
|
|
|
ADH2
|
[NCBI]
|
6.28035e-05
|
|
|
FRDA
|
[NCBI]
|
6.24702e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
6.22217e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
6.22217e-05
|
|
|
HD
|
[NCBI]
|
6.21061e-05
|
|
|
APOE
|
[NCBI]
|
6.12729e-05
|
|
|
PSNP1
|
[NCBI]
|
6.05178e-05
|
|
|
USH2A
|
[NCBI]
|
6.05178e-05
|
|
|
CLN1
|
[NCBI]
|
6.05178e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
6.05178e-05
|
|
|
NOS2A
|
[NCBI]
|
6.02743e-05
|
|
|
SGCG
|
[NCBI]
|
5.97393e-05
|
|
|
osteoporosis
|
[NCBI]
|
5.8897e-05
|
|
|
alcohol dependence
|
[NCBI]
|
5.8897e-05
|
|
|
CHH
|
[NCBI]
|
5.88096e-05
|
|
|
IL1A
|
[NCBI]
|
5.87342e-05
|
|
|
epstein-barr virus, susceptibility to chronic infection by
|
[NCBI]
|
5.86813e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
5.86813e-05
|
|
|
SHEP5
|
[NCBI]
|
5.86813e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
5.86813e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
5.86813e-05
|
|
|
SLEB2
|
[NCBI]
|
5.86813e-05
|
|
|
loc387715 gene
|
[NCBI]
|
5.79641e-05
|
|
|
VEGF
|
[NCBI]
|
5.68203e-05
|
|
|
DYX1
|
[NCBI]
|
5.5877e-05
|
|
|
OLR1
|
[NCBI]
|
5.48835e-05
|
|
|
FCRL3
|
[NCBI]
|
5.39171e-05
|
|
|
HAE III
|
[NCBI]
|
5.20353e-05
|
|
|
FIDD
|
[NCBI]
|
5.20353e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
5.20353e-05
|
|
|
USH1F
|
[NCBI]
|
5.20353e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
5.20353e-05
|
|
|
EEG
|
[NCBI]
|
5.20353e-05
|
|
|
LI3
|
[NCBI]
|
5.20353e-05
|
|
|
FHCA
|
[NCBI]
|
5.20353e-05
|
|
|
VDR
|
[NCBI]
|
5.11966e-05
|
|
|
PLIN
|
[NCBI]
|
5.11032e-05
|
|
|
graves disease
|
[NCBI]
|
5.05733e-05
|
|
|
LGMD2C
|
[NCBI]
|
4.93759e-05
|
|
|
RP
|
[NCBI]
|
4.87253e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
4.82231e-05
|
|
|
ODG1
|
[NCBI]
|
4.71349e-05
|
|
|
IDDM12
|
[NCBI]
|
4.71349e-05
|
|
|
cd4/cd8 t-cell ratio
|
[NCBI]
|
4.71349e-05
|
|
|
pseudodiastrophic dysplasia
|
[NCBI]
|
4.71349e-05
|
|
|
SCZD8
|
[NCBI]
|
4.71349e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
4.71349e-05
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
4.71349e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
4.71349e-05
|
|
|
LI2
|
[NCBI]
|
4.71349e-05
|
|
|
LPL
|
[NCBI]
|
4.69135e-05
|
|
|
wilson disease
|
[NCBI]
|
4.54572e-05
|
|
|
GLMN
|
[NCBI]
|
4.53071e-05
|
|
|
ADAM33
|
[NCBI]
|
4.53071e-05
|
|
|
DCDC2
|
[NCBI]
|
4.53071e-05
|
|
|
CAPN10
|
[NCBI]
|
4.46099e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
4.40049e-05
|
|
|
CLN3
|
[NCBI]
|
4.40049e-05
|
|
|
protocadherin-beta gene cluster
|
[NCBI]
|
4.32626e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
4.32626e-05
|
|
|
ATCAY
|
[NCBI]
|
4.32626e-05
|
|
|
OCA4
|
[NCBI]
|
4.32626e-05
|
|
|
CNA2
|
[NCBI]
|
4.32626e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
4.32626e-05
|
|
|
elejalde disease
|
[NCBI]
|
4.32626e-05
|
|
|
LRP5
|
[NCBI]
|
4.31373e-05
|
|
|
lactase persistence
|
[NCBI]
|
4.30374e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
4.30374e-05
|
|
|
CDG1A
|
[NCBI]
|
4.30374e-05
|
|
|
COH1
|
[NCBI]
|
4.30374e-05
|
|
|
IL4R
|
[NCBI]
|
4.17845e-05
|
|
|
FA
|
[NCBI]
|
4.09705e-05
|
|
|
SLC30A8
|
[NCBI]
|
4.04613e-05
|
|
|
ADH4
|
[NCBI]
|
4.04613e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
4.04613e-05
|
|
|
RENBP
|
[NCBI]
|
4.04613e-05
|
|
|
IL23R
|
[NCBI]
|
4.04613e-05
|
|
|
CCR5
|
[NCBI]
|
4.03004e-05
|
|
|
TH
|
[NCBI]
|
4.02438e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
4.00696e-05
|
|
|
ARMD7
|
[NCBI]
|
4.00696e-05
|
|
|
LSFC
|
[NCBI]
|
4.00696e-05
|
|
|
ACE
|
[NCBI]
|
3.98841e-05
|
|
|
IGER
|
[NCBI]
|
3.94608e-05
|
|
|
PRODH
|
[NCBI]
|
3.93719e-05
|
|
|
MPO
|
[NCBI]
|
3.92943e-05
|
|
|
HSD17B1
|
[NCBI]
|
3.8637e-05
|
|
|
CCHCR1
|
[NCBI]
|
3.8637e-05
|
|
|
SCA1
|
[NCBI]
|
3.79664e-05
|
|
|
IDUA
|
[NCBI]
|
3.73689e-05
|
|
|
TRMA
|
[NCBI]
|
3.73594e-05
|
|
|
GS1
|
[NCBI]
|
3.73594e-05
|
|
|
vitiligo
|
[NCBI]
|
3.73594e-05
|
|
|
PARK7
|
[NCBI]
|
3.73594e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
3.73594e-05
|
|
|
PARK4
|
[NCBI]
|
3.73594e-05
|
|
|
VMCM
|
[NCBI]
|
3.73594e-05
|
|
|
char syndrome
|
[NCBI]
|
3.73594e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
3.73594e-05
|
|
|
DFNB3
|
[NCBI]
|
3.73594e-05
|
|
|
IDD
|
[NCBI]
|
3.73594e-05
|
|
|
JBTS3
|
[NCBI]
|
3.73594e-05
|
|
|
NOTCH4
|
[NCBI]
|
3.70632e-05
|
|
|
AFP
|
[NCBI]
|
3.69174e-05
|
|
|
PON1
|
[NCBI]
|
3.651e-05
|
|
|
DYT1
|
[NCBI]
|
3.62873e-05
|
|
|
CRC
|
[NCBI]
|
3.58769e-05
|
|
|
HTRA1
|
[NCBI]
|
3.56799e-05
|
|
|
SCA6
|
[NCBI]
|
3.55483e-05
|
|
|
OCA3
|
[NCBI]
|
3.50103e-05
|
|
|
GS2
|
[NCBI]
|
3.50103e-05
|
|
|
CLPED1
|
[NCBI]
|
3.50103e-05
|
|
|
NIDDM1
|
[NCBI]
|
3.50103e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
3.50103e-05
|
|
|
NOD2
|
[NCBI]
|
3.49763e-05
|
|
|
PKLR
|
[NCBI]
|
3.49763e-05
|
|
|
SLC17A5
|
[NCBI]
|
3.44463e-05
|
|
|
RGS4
|
[NCBI]
|
3.44463e-05
|
|
|
INPPL1
|
[NCBI]
|
3.44463e-05
|
|
|
INSIG2
|
[NCBI]
|
3.44463e-05
|
|
|
CCL4
|
[NCBI]
|
3.44463e-05
|
|
|
NPPB
|
[NCBI]
|
3.44463e-05
|
|
|
AD
|
[NCBI]
|
3.41618e-05
|
|
|
CTLA4
|
[NCBI]
|
3.37433e-05
|
|
|
ADH3
|
[NCBI]
|
3.33335e-05
|
|
|
SLC7A9
|
[NCBI]
|
3.33335e-05
|
|
|
MLC1
|
[NCBI]
|
3.33335e-05
|
|
|
PON2
|
[NCBI]
|
3.33335e-05
|
|
|
PARK1
|
[NCBI]
|
3.29414e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
3.29414e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
3.29414e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
3.29414e-05
|
|
|
USH1D
|
[NCBI]
|
3.29414e-05
|
|
|
MHS1
|
[NCBI]
|
3.27818e-05
|
|
|
CYP4F22
|
[NCBI]
|
3.26236e-05
|
|
|
g8 protein
|
[NCBI]
|
3.26236e-05
|
|
|
MIAT
|
[NCBI]
|
3.26236e-05
|
|
|
AIRE
|
[NCBI]
|
3.25515e-05
|
|
|
FKTN
|
[NCBI]
|
3.23203e-05
|
|
|
KIR3DL1
|
[NCBI]
|
3.23203e-05
|
|
|
HHEX
|
[NCBI]
|
3.23203e-05
|
|
|
OLIG2
|
[NCBI]
|
3.23203e-05
|
|
|
SCA7
|
[NCBI]
|
3.21338e-05
|
|
|
IKBKAP
|
[NCBI]
|
3.13906e-05
|
|
|
CCK
|
[NCBI]
|
3.12335e-05
|
|
|
CPB2
|
[NCBI]
|
3.11141e-05
|
|
|
SCZD2
|
[NCBI]
|
3.10963e-05
|
|
|
SCAR1
|
[NCBI]
|
3.10963e-05
|
|
|
FTD
|
[NCBI]
|
3.06462e-05
|
|
|
CCL3
|
[NCBI]
|
3.05319e-05
|
|
|
VWS
|
[NCBI]
|
3.02834e-05
|
|
|
HFE
|
[NCBI]
|
3.00475e-05
|
|
|
ME2
|
[NCBI]
|
2.97344e-05
|
|
|
SSTR5
|
[NCBI]
|
2.97344e-05
|
|
|
MTC
|
[NCBI]
|
2.94343e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
2.94343e-05
|
|
|
SACS
|
[NCBI]
|
2.94343e-05
|
|
|
sarcoidosis
|
[NCBI]
|
2.94343e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
2.94343e-05
|
|
|
SEDT
|
[NCBI]
|
2.94343e-05
|
|
|
IHPS1
|
[NCBI]
|
2.94343e-05
|
|
|
PPARG
|
[NCBI]
|
2.90568e-05
|
|
|
NPHS1
|
[NCBI]
|
2.89901e-05
|
|
|
CYP1A2
|
[NCBI]
|
2.89901e-05
|
|
|
TPH1
|
[NCBI]
|
2.89901e-05
|
|
|
ESR1
|
[NCBI]
|
2.88806e-05
|
|
|
DRD2
|
[NCBI]
|
2.87172e-05
|
|
|
IL7R
|
[NCBI]
|
2.82926e-05
|
|
|
SLC45A2
|
[NCBI]
|
2.82926e-05
|
|
|
SHEP1
|
[NCBI]
|
2.79245e-05
|
|
|
ACCPN
|
[NCBI]
|
2.79245e-05
|
|
|
alzheimer disease 2
|
[NCBI]
|
2.79245e-05
|
|
|
NM
|
[NCBI]
|
2.79245e-05
|
|
|
ARH
|
[NCBI]
|
2.79245e-05
|
|
|
CMT2A1
|
[NCBI]
|
2.79245e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
2.79245e-05
|
|
|
autoimmune disease
|
[NCBI]
|
2.79245e-05
|
|
|
BMND1
|
[NCBI]
|
2.79245e-05
|
|
|
NCIE1
|
[NCBI]
|
2.79245e-05
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
2.79245e-05
|
|
|
ED2
|
[NCBI]
|
2.79245e-05
|
|
|
DSMA1
|
[NCBI]
|
2.79245e-05
|
|
|
SLC11A1
|
[NCBI]
|
2.78834e-05
|
|
|
UCHL1
|
[NCBI]
|
2.76365e-05
|
|
|
CPI
|
[NCBI]
|
2.74255e-05
|
|
|
SPR
|
[NCBI]
|
2.70172e-05
|
|
|
PTPN22
|
[NCBI]
|
2.70172e-05
|
|
|
HGF
|
[NCBI]
|
2.68282e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
2.65437e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
2.65437e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
2.65437e-05
|
|
|
CDS
|
[NCBI]
|
2.65437e-05
|
|
|
sitosterolemia
|
[NCBI]
|
2.65437e-05
|
|
|
LGMD1B
|
[NCBI]
|
2.65437e-05
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
2.65437e-05
|
|
|
HSCR2
|
[NCBI]
|
2.65437e-05
|
|
|
USH1C
|
[NCBI]
|
2.65437e-05
|
|
|
NCSTN
|
[NCBI]
|
2.64311e-05
|
|
|
TGFB1
|
[NCBI]
|
2.63437e-05
|
|
|
DDC
|
[NCBI]
|
2.59728e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.59425e-05
|
|
|
HLA-G
|
[NCBI]
|
2.58748e-05
|
|
|
MEN2A
|
[NCBI]
|
2.54525e-05
|
|
|
CHAT
|
[NCBI]
|
2.54278e-05
|
|
|
IL1RN
|
[NCBI]
|
2.53456e-05
|
|
|
GAN1
|
[NCBI]
|
2.52732e-05
|
|
|
propionic acidemia
|
[NCBI]
|
2.52732e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
2.52732e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.52002e-05
|
|
|
DRD4
|
[NCBI]
|
2.49499e-05
|
|
|
PLAT
|
[NCBI]
|
2.48411e-05
|
|
|
MBP
|
[NCBI]
|
2.47212e-05
|
|
|
TBCD
|
[NCBI]
|
2.44007e-05
|
|
|
CCDC28B
|
[NCBI]
|
2.44007e-05
|
|
|
THBS4
|
[NCBI]
|
2.44007e-05
|
|
|
ichthyin
|
[NCBI]
|
2.44007e-05
|
|
|
TAS2R38
|
[NCBI]
|
2.44007e-05
|
|
|
mapbp-interacting protein
|
[NCBI]
|
2.44007e-05
|
|
|
BAT2
|
[NCBI]
|
2.44007e-05
|
|
|
PGLYRP4
|
[NCBI]
|
2.44007e-05
|
|
|
CHI3L2
|
[NCBI]
|
2.44007e-05
|
|
|
HLA8
|
[NCBI]
|
2.44007e-05
|
|
|
KIAA1109
|
[NCBI]
|
2.44007e-05
|
|
|
PGLYRP3
|
[NCBI]
|
2.44007e-05
|
|
|
pin2-interacting protein 1
|
[NCBI]
|
2.44007e-05
|
|
|
kiaa0319 gene
|
[NCBI]
|
2.44007e-05
|
|
|
MED12L
|
[NCBI]
|
2.44007e-05
|
|
|
MTNR1B
|
[NCBI]
|
2.44007e-05
|
|
|
CJD
|
[NCBI]
|
2.43714e-05
|
|
|
CDSN
|
[NCBI]
|
2.43591e-05
|
|
|
MSX1
|
[NCBI]
|
2.43591e-05
|
|
|
CYP11B1
|
[NCBI]
|
2.43591e-05
|
|
|
PARK6
|
[NCBI]
|
2.40983e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
2.40983e-05
|
|
|
VED
|
[NCBI]
|
2.40983e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
2.38979e-05
|
|
|
TS
|
[NCBI]
|
2.34439e-05
|
|
|
EIG
|
[NCBI]
|
2.33077e-05
|
|
|
SNCA
|
[NCBI]
|
2.32792e-05
|
|
|
hypertension, essential
|
[NCBI]
|
2.31526e-05
|
|
|
AHSG
|
[NCBI]
|
2.30311e-05
|
|
|
CD4
|
[NCBI]
|
2.30311e-05
|
|
|
refsum disease
|
[NCBI]
|
2.30071e-05
|
|
|
SCZD1
|
[NCBI]
|
2.30071e-05
|
|
|
EDC
|
[NCBI]
|
2.30071e-05
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
2.30071e-05
|
|
|
TAF1
|
[NCBI]
|
2.223e-05
|
|
|
LCT
|
[NCBI]
|
2.19639e-05
|
|
|
UCP3
|
[NCBI]
|
2.17857e-05
|
|
|
SLE
|
[NCBI]
|
2.16848e-05
|
|
|
IL1B
|
[NCBI]
|
2.14856e-05
|
|
|
NPC1
|
[NCBI]
|
2.14856e-05
|
|
|
KCNJ11
|
[NCBI]
|
2.14856e-05
|
|
|
CSTB
|
[NCBI]
|
2.14856e-05
|
|
|
SCA2
|
[NCBI]
|
2.14754e-05
|
|
|
GBA
|
[NCBI]
|
2.14363e-05
|
|
|
SLC6A3
|
[NCBI]
|
2.13133e-05
|
|
|
PCDHA10
|
[NCBI]
|
2.13125e-05
|
|
|
RBM17
|
[NCBI]
|
2.13125e-05
|
|
|
TAAR6
|
[NCBI]
|
2.13125e-05
|
|
|
PADI3
|
[NCBI]
|
2.13125e-05
|
|
|
caytaxin
|
[NCBI]
|
2.13125e-05
|
|
|
ADH6
|
[NCBI]
|
2.13125e-05
|
|
|
DCTD
|
[NCBI]
|
2.13125e-05
|
|
|
ABHD5
|
[NCBI]
|
2.13125e-05
|
|
|
FXYD6
|
[NCBI]
|
2.13125e-05
|
|
|
CUL5
|
[NCBI]
|
2.13125e-05
|
|
|
PADI1
|
[NCBI]
|
2.13125e-05
|
|
|
SCG3
|
[NCBI]
|
2.13125e-05
|
|
|
PADI2
|
[NCBI]
|
2.13125e-05
|
|
|
PCDHA8
|
[NCBI]
|
2.13125e-05
|
|
|
glutathione s-transferase, omega-1
|
[NCBI]
|
2.13125e-05
|
|
|
CYP2C18
|
[NCBI]
|
2.13125e-05
|
|
|
AS3MT
|
[NCBI]
|
2.13125e-05
|
|
|
USP24
|
[NCBI]
|
2.13125e-05
|
|
|
WNT5B
|
[NCBI]
|
2.13125e-05
|
|
|
COL6A1
|
[NCBI]
|
2.11324e-05
|
|
|
breast cancer
|
[NCBI]
|
2.10766e-05
|
|
|
IBM2
|
[NCBI]
|
2.10379e-05
|
|
|
JBS
|
[NCBI]
|
2.10379e-05
|
|
|
IL12B
|
[NCBI]
|
2.07909e-05
|
|
|
oca2 gene
|
[NCBI]
|
2.07909e-05
|
|
|
FASN
|
[NCBI]
|
2.07909e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.03882e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
2.01447e-05
|
|
|
PARK8
|
[NCBI]
|
2.01447e-05
|
|
|
PLOSL
|
[NCBI]
|
2.01447e-05
|
|
|
HEPOD
|
[NCBI]
|
2.01447e-05
|
|
|
LEPR
|
[NCBI]
|
2.0122e-05
|
|
|
MDD
|
[NCBI]
|
1.95075e-05
|
|
|
ITPKC
|
[NCBI]
|
1.93156e-05
|
|
|
COLEC12
|
[NCBI]
|
1.93156e-05
|
|
|
CTNNA3
|
[NCBI]
|
1.93156e-05
|
|
|
BAAT
|
[NCBI]
|
1.93156e-05
|
|
|
DNMBP
|
[NCBI]
|
1.93156e-05
|
|
|
VAMP4
|
[NCBI]
|
1.93156e-05
|
|
|
LRMP
|
[NCBI]
|
1.93156e-05
|
|
|
PCM1
|
[NCBI]
|
1.93156e-05
|
|
|
IL1R2
|
[NCBI]
|
1.93156e-05
|
|
|
CLINT1
|
[NCBI]
|
1.93156e-05
|
|
|
RDH8
|
[NCBI]
|
1.93156e-05
|
|
|
CTDP1
|
[NCBI]
|
1.93156e-05
|
|
|
PLEKHA1
|
[NCBI]
|
1.93156e-05
|
|
|
SLC6A14
|
[NCBI]
|
1.93156e-05
|
|
|
CHGB
|
[NCBI]
|
1.93156e-05
|
|
|
ZNF202
|
[NCBI]
|
1.93156e-05
|
|
|
PSMB8
|
[NCBI]
|
1.93156e-05
|
|
|
BTBD9
|
[NCBI]
|
1.93156e-05
|
|
|
SRR
|
[NCBI]
|
1.93156e-05
|
|
|
ALOXE3
|
[NCBI]
|
1.93156e-05
|
|
|
TPST1
|
[NCBI]
|
1.93156e-05
|
|
|
LRP4
|
[NCBI]
|
1.93156e-05
|
|
|
L2HGDH
|
[NCBI]
|
1.93156e-05
|
|
|
PFN2
|
[NCBI]
|
1.93156e-05
|
|
|
CDH12
|
[NCBI]
|
1.93156e-05
|
|
|
ZNF350
|
[NCBI]
|
1.93156e-05
|
|
|
GABRB1
|
[NCBI]
|
1.93156e-05
|
|
|
EDMD2
|
[NCBI]
|
1.93043e-05
|
|
|
ALDH2
|
[NCBI]
|
1.92355e-05
|
|
|
ADRB2
|
[NCBI]
|
1.89511e-05
|
|
|
MICA
|
[NCBI]
|
1.89511e-05
|
|
|
BLM
|
[NCBI]
|
1.88389e-05
|
|
|
EDNRB
|
[NCBI]
|
1.86745e-05
|
|
|
MYOC
|
[NCBI]
|
1.86433e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
1.85117e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
1.85117e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
1.85117e-05
|
|
|
ATP7B
|
[NCBI]
|
1.84054e-05
|
|
|
EDN1
|
[NCBI]
|
1.84054e-05
|
|
|
FY
|
[NCBI]
|
1.84054e-05
|
|
|
CDA
|
[NCBI]
|
1.81433e-05
|
|
|
MAOA
|
[NCBI]
|
1.79627e-05
|
|
|
ABCA4
|
[NCBI]
|
1.7888e-05
|
|
|
MMP3
|
[NCBI]
|
1.7888e-05
|
|
|
DHFR
|
[NCBI]
|
1.78396e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.78396e-05
|
|
|
SLC25A12
|
[NCBI]
|
1.78371e-05
|
|
|
TAAR5
|
[NCBI]
|
1.78371e-05
|
|
|
PPP1R11
|
[NCBI]
|
1.78371e-05
|
|
|
CYSLTR2
|
[NCBI]
|
1.78371e-05
|
|
|
COMMD1
|
[NCBI]
|
1.78371e-05
|
|
|
NPY2R
|
[NCBI]
|
1.78371e-05
|
|
|
SLC14A2
|
[NCBI]
|
1.78371e-05
|
|
|
CD63
|
[NCBI]
|
1.78371e-05
|
|
|
ABCA12
|
[NCBI]
|
1.78371e-05
|
|
|
GPR44
|
[NCBI]
|
1.78371e-05
|
|
|
GPR74
|
[NCBI]
|
1.78371e-05
|
|
|
CDKAL1
|
[NCBI]
|
1.78371e-05
|
|
|
FADS1
|
[NCBI]
|
1.78371e-05
|
|
|
PCDHA9
|
[NCBI]
|
1.78371e-05
|
|
|
ADH7
|
[NCBI]
|
1.78371e-05
|
|
|
PLXNA2
|
[NCBI]
|
1.78371e-05
|
|
|
GABRA6
|
[NCBI]
|
1.78371e-05
|
|
|
MX1
|
[NCBI]
|
1.78371e-05
|
|
|
TJP2
|
[NCBI]
|
1.78371e-05
|
|
|
IRAK3
|
[NCBI]
|
1.78371e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
1.77626e-05
|
|
|
MSD
|
[NCBI]
|
1.77626e-05
|
|
|
MLC
|
[NCBI]
|
1.77626e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
1.77626e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
1.77626e-05
|
|
|
BDNF
|
[NCBI]
|
1.74641e-05
|
|
|
PRNP
|
[NCBI]
|
1.73475e-05
|
|
|
IL2RA
|
[NCBI]
|
1.71596e-05
|
|
|
TCRA
|
[NCBI]
|
1.71596e-05
|
|
|
CRMO
|
[NCBI]
|
1.7053e-05
|
|
|
CMM2
|
[NCBI]
|
1.7053e-05
|
|
|
RELN
|
[NCBI]
|
1.69284e-05
|
|
|
FMR1
|
[NCBI]
|
1.66677e-05
|
|
|
CES2
|
[NCBI]
|
1.66639e-05
|
|
|
CLEC16A
|
[NCBI]
|
1.66639e-05
|
|
|
ARNT2
|
[NCBI]
|
1.66639e-05
|
|
|
HTR7
|
[NCBI]
|
1.66639e-05
|
|
|
ALPPL2
|
[NCBI]
|
1.66639e-05
|
|
|
SLC22A3
|
[NCBI]
|
1.66639e-05
|
|
|
MYO10
|
[NCBI]
|
1.66639e-05
|
|
|
BTNL2
|
[NCBI]
|
1.66639e-05
|
|
|
KIR2DL2
|
[NCBI]
|
1.66639e-05
|
|
|
NOD1
|
[NCBI]
|
1.66639e-05
|
|
|
E2F2
|
[NCBI]
|
1.66639e-05
|
|
|
MTF1
|
[NCBI]
|
1.66639e-05
|
|
|
ALOX12B
|
[NCBI]
|
1.66639e-05
|
|
|
SYN2
|
[NCBI]
|
1.66639e-05
|
|
|
TIRAP
|
[NCBI]
|
1.66639e-05
|
|
|
IMPA2
|
[NCBI]
|
1.66639e-05
|
|
|
GABRA4
|
[NCBI]
|
1.66639e-05
|
|
|
KIF11
|
[NCBI]
|
1.66639e-05
|
|
|
TBX19
|
[NCBI]
|
1.66639e-05
|
|
|
PADI4
|
[NCBI]
|
1.66639e-05
|
|
|
CDAN1
|
[NCBI]
|
1.66639e-05
|
|
|
KMO
|
[NCBI]
|
1.66639e-05
|
|
|
MMP10
|
[NCBI]
|
1.66639e-05
|
|
|
CNTN4
|
[NCBI]
|
1.66639e-05
|
|
|
CRMP1
|
[NCBI]
|
1.66639e-05
|
|
|
PON3
|
[NCBI]
|
1.66639e-05
|
|
|
ADRA2C
|
[NCBI]
|
1.66639e-05
|
|
|
MLX
|
[NCBI]
|
1.66639e-05
|
|
|
thiourea tasting
|
[NCBI]
|
1.63798e-05
|
|
|
AKT1
|
[NCBI]
|
1.62663e-05
|
|
|
DAO
|
[NCBI]
|
1.5849e-05
|
|
|
SMA2
|
[NCBI]
|
1.574e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
1.574e-05
|
|
|
LCA1
|
[NCBI]
|
1.574e-05
|
|
|
CAPN1
|
[NCBI]
|
1.56925e-05
|
|
|
BRD2
|
[NCBI]
|
1.56925e-05
|
|
|
FBXO15
|
[NCBI]
|
1.56925e-05
|
|
|
LIPG
|
[NCBI]
|
1.56925e-05
|
|
|
WNT2
|
[NCBI]
|
1.56925e-05
|
|
|
SLURP1
|
[NCBI]
|
1.56925e-05
|
|
|
DGCR14
|
[NCBI]
|
1.56925e-05
|
|
|
TSN
|
[NCBI]
|
1.56925e-05
|
|
|
SUMO4
|
[NCBI]
|
1.56925e-05
|
|
|
P2RY14
|
[NCBI]
|
1.56925e-05
|
|
|
MPP1
|
[NCBI]
|
1.56925e-05
|
|
|
SORL1
|
[NCBI]
|
1.56925e-05
|
|
|
PDE6G
|
[NCBI]
|
1.56925e-05
|
|
|
CCL7
|
[NCBI]
|
1.56925e-05
|
|
|
locus control region, beta
|
[NCBI]
|
1.56925e-05
|
|
|
PPARGC1B
|
[NCBI]
|
1.56925e-05
|
|
|
ADIPOR2
|
[NCBI]
|
1.56925e-05
|
|
|
TAP2
|
[NCBI]
|
1.56925e-05
|
|
|
TRMU
|
[NCBI]
|
1.56925e-05
|
|
|
FOXJ1
|
[NCBI]
|
1.56925e-05
|
|
|
APS1
|
[NCBI]
|
1.56217e-05
|
|
|
EVC
|
[NCBI]
|
1.5131e-05
|
|
|
MSH2
|
[NCBI]
|
1.50661e-05
|
|
|
PGM1
|
[NCBI]
|
1.48802e-05
|
|
|
RNU2
|
[NCBI]
|
1.48644e-05
|
|
|
TAS2R16
|
[NCBI]
|
1.48644e-05
|
|
|
AVPR1A
|
[NCBI]
|
1.48644e-05
|
|
|
NNT
|
[NCBI]
|
1.48644e-05
|
|
|
OPRK1
|
[NCBI]
|
1.48644e-05
|
|
|
BAT1
|
[NCBI]
|
1.48644e-05
|
|
|
PODXL
|
[NCBI]
|
1.48644e-05
|
|
|
IFNAR2
|
[NCBI]
|
1.48644e-05
|
|
|
S100A7
|
[NCBI]
|
1.48644e-05
|
|
|
IL10RB
|
[NCBI]
|
1.48644e-05
|
|
|
BCS1L
|
[NCBI]
|
1.48644e-05
|
|
|
CCL4L1
|
[NCBI]
|
1.48644e-05
|
|
|
CVID
|
[NCBI]
|
1.48002e-05
|
|
|
CRH
|
[NCBI]
|
1.47296e-05
|
|
|
IGF2
|
[NCBI]
|
1.45193e-05
|
|
|
behcet syndrome
|
[NCBI]
|
1.4485e-05
|
|
|
MMP9
|
[NCBI]
|
1.4172e-05
|
|
|
SIPA1
|
[NCBI]
|
1.41436e-05
|
|
|
IL21R
|
[NCBI]
|
1.41436e-05
|
|
|
RABAC1
|
[NCBI]
|
1.41436e-05
|
|
|
MYLK
|
[NCBI]
|
1.41436e-05
|
|
|
SACS
|
[NCBI]
|
1.41436e-05
|
|
|
NEUROG3
|
[NCBI]
|
1.41436e-05
|
|
|
ACTN3
|
[NCBI]
|
1.41436e-05
|
|
|
COL9A2
|
[NCBI]
|
1.41436e-05
|
|
|
GNAL
|
[NCBI]
|
1.41436e-05
|
|
|
SDC3
|
[NCBI]
|
1.41436e-05
|
|
|
CCL3L1
|
[NCBI]
|
1.41436e-05
|
|
|
SIRT3
|
[NCBI]
|
1.41436e-05
|
|
|
FCAR
|
[NCBI]
|
1.41436e-05
|
|
|
AHI1
|
[NCBI]
|
1.41436e-05
|
|
|
DNASE1
|
[NCBI]
|
1.41436e-05
|
|
|
SCGB3A2
|
[NCBI]
|
1.41436e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
1.39968e-05
|
|
|
ABCB1
|
[NCBI]
|
1.37477e-05
|
|
|
CYP19A1
|
[NCBI]
|
1.3675e-05
|
|
|
CHRNA7
|
[NCBI]
|
1.35059e-05
|
|
|
IL9R
|
[NCBI]
|
1.35059e-05
|
|
|
SLC19A2
|
[NCBI]
|
1.35059e-05
|
|
|
CYP2E
|
[NCBI]
|
1.35059e-05
|
|
|
ICSBP1
|
[NCBI]
|
1.35059e-05
|
|
|
PRKG1
|
[NCBI]
|
1.35059e-05
|
|
|
SETX
|
[NCBI]
|
1.35059e-05
|
|
|
PSMB9
|
[NCBI]
|
1.35059e-05
|
|
|
TACSTD2
|
[NCBI]
|
1.35059e-05
|
|
|
CD19
|
[NCBI]
|
1.35059e-05
|
|
|
CD36
|
[NCBI]
|
1.32041e-05
|
|
|
IL6
|
[NCBI]
|
1.31145e-05
|
|
|
FPLD2
|
[NCBI]
|
1.29614e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.29563e-05
|
|
|
AAAS
|
[NCBI]
|
1.29347e-05
|
|
|
PRKAA2
|
[NCBI]
|
1.29347e-05
|
|
|
SGCB
|
[NCBI]
|
1.29347e-05
|
|
|
KERA
|
[NCBI]
|
1.29347e-05
|
|
|
NPHP1
|
[NCBI]
|
1.29347e-05
|
|
|
HTR1B
|
[NCBI]
|
1.29347e-05
|
|
|
ACO2
|
[NCBI]
|
1.29347e-05
|
|
|
TRAF1
|
[NCBI]
|
1.29347e-05
|
|
|
PRND
|
[NCBI]
|
1.29347e-05
|
|
|
MDM1
|
[NCBI]
|
1.29347e-05
|
|
|
CCL5
|
[NCBI]
|
1.29347e-05
|
|
|
AMN
|
[NCBI]
|
1.29347e-05
|
|
|
CD
|
[NCBI]
|
1.28165e-05
|
|
|
gastric cancer
|
[NCBI]
|
1.24769e-05
|
|
|
DJS
|
[NCBI]
|
1.24769e-05
|
|
|
FCHL
|
[NCBI]
|
1.24769e-05
|
|
|
cystinuria
|
[NCBI]
|
1.24769e-05
|
|
|
UBQLN1
|
[NCBI]
|
1.24179e-05
|
|
|
HPS1
|
[NCBI]
|
1.24179e-05
|
|
|
SOST
|
[NCBI]
|
1.24179e-05
|
|
|
MYO15A
|
[NCBI]
|
1.24179e-05
|
|
|
GNPAT
|
[NCBI]
|
1.24179e-05
|
|
|
CX3CR1
|
[NCBI]
|
1.24179e-05
|
|
|
MCPH1
|
[NCBI]
|
1.24179e-05
|
|
|
ZNF9
|
[NCBI]
|
1.24179e-05
|
|
|
TFAP2B
|
[NCBI]
|
1.24179e-05
|
|
|
MS4A2
|
[NCBI]
|
1.24179e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.24179e-05
|
|
|
IRF5
|
[NCBI]
|
1.24179e-05
|
|
|
ASPM
|
[NCBI]
|
1.24179e-05
|
|
|
temporal arteritis
|
[NCBI]
|
1.2063e-05
|
|
|
PARK2
|
[NCBI]
|
1.20125e-05
|
|
|
LGMD2A
|
[NCBI]
|
1.20125e-05
|
|
|
FCGR2B
|
[NCBI]
|
1.19463e-05
|
|
|
LTA4H
|
[NCBI]
|
1.19463e-05
|
|
|
PDCD5
|
[NCBI]
|
1.19463e-05
|
|
|
SILV
|
[NCBI]
|
1.19463e-05
|
|
|
SELL
|
[NCBI]
|
1.19463e-05
|
|
|
RMRP
|
[NCBI]
|
1.19463e-05
|
|
|
KLK1
|
[NCBI]
|
1.19463e-05
|
|
|
PAPSS2
|
[NCBI]
|
1.19463e-05
|
|
|
NDRG1
|
[NCBI]
|
1.19463e-05
|
|
|
PARK2
|
[NCBI]
|
1.17961e-05
|
|
|
CMD1A
|
[NCBI]
|
1.15671e-05
|
|
|
BMP2
|
[NCBI]
|
1.15404e-05
|
|
|
MED12
|
[NCBI]
|
1.15129e-05
|
|
|
EN2
|
[NCBI]
|
1.15129e-05
|
|
|
HLA-C
|
[NCBI]
|
1.15129e-05
|
|
|
MCOLN1
|
[NCBI]
|
1.15129e-05
|
|
|
DRD1
|
[NCBI]
|
1.15129e-05
|
|
|
ADH1
|
[NCBI]
|
1.15129e-05
|
|
|
SFTPA1
|
[NCBI]
|
1.15129e-05
|
|
|
MSR1
|
[NCBI]
|
1.15129e-05
|
|
|
PDE4D
|
[NCBI]
|
1.15129e-05
|
|
|
PVRL1
|
[NCBI]
|
1.15129e-05
|
|
|
TSHR
|
[NCBI]
|
1.14155e-05
|
|
|
OCA2
|
[NCBI]
|
1.11396e-05
|
|
|
CDPX2
|
[NCBI]
|
1.11396e-05
|
|
|
PCTT
|
[NCBI]
|
1.11396e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.11396e-05
|
|
|
DVL1
|
[NCBI]
|
1.11124e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.11124e-05
|
|
|
CCL18
|
[NCBI]
|
1.11124e-05
|
|
|
PCSK9
|
[NCBI]
|
1.11124e-05
|
|
|
APOC3
|
[NCBI]
|
1.11124e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.10517e-05
|
|
|
TYMS
|
[NCBI]
|
1.08577e-05
|
|
|
NTF3
|
[NCBI]
|
1.07402e-05
|
|
|
ATRN
|
[NCBI]
|
1.07402e-05
|
|
|
POU5F1
|
[NCBI]
|
1.07402e-05
|
|
|
LIG4
|
[NCBI]
|
1.07402e-05
|
|
|
TAP1
|
[NCBI]
|
1.07402e-05
|
|
|
SOCS2
|
[NCBI]
|
1.07402e-05
|
|
|
SGSH
|
[NCBI]
|
1.07402e-05
|
|
|
HPSE
|
[NCBI]
|
1.07402e-05
|
|
|
FOXP2
|
[NCBI]
|
1.07402e-05
|
|
|
PDCD1
|
[NCBI]
|
1.07402e-05
|
|
|
ECE1
|
[NCBI]
|
1.07402e-05
|
|
|
OPA1
|
[NCBI]
|
1.07289e-05
|
|
|
MEB
|
[NCBI]
|
1.07289e-05
|
|
|
FIH
|
[NCBI]
|
1.07289e-05
|
|
|
NFKBIA
|
[NCBI]
|
1.03929e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
1.03929e-05
|
|
|
MC3R
|
[NCBI]
|
1.03929e-05
|
|
|
TERF1
|
[NCBI]
|
1.03929e-05
|
|
|
GABRB3
|
[NCBI]
|
1.03929e-05
|
|
|
PNPLA2
|
[NCBI]
|
1.03929e-05
|
|
|
PLA2G2A
|
[NCBI]
|
1.03929e-05
|
|
|
ELAC2
|
[NCBI]
|
1.03929e-05
|
|
|
SLC26A2
|
[NCBI]
|
1.03929e-05
|
|
|
SLC19A1
|
[NCBI]
|
1.03929e-05
|
|
|
GPR24
|
[NCBI]
|
1.03929e-05
|
|
|
ATXN3
|
[NCBI]
|
1.03929e-05
|
|
|
SELE
|
[NCBI]
|
1.03929e-05
|
|
|
OCA1A
|
[NCBI]
|
1.03341e-05
|
|
|
ADA
|
[NCBI]
|
1.02696e-05
|
|
|
CAST
|
[NCBI]
|
1.00675e-05
|
|
|
APOM
|
[NCBI]
|
1.00675e-05
|
|
|
RNASEL
|
[NCBI]
|
1.00675e-05
|
|
|
USH2A
|
[NCBI]
|
1.00675e-05
|
|
|
HEXA
|
[NCBI]
|
1.00493e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
9.95443e-06
|
|
|
COL2A1
|
[NCBI]
|
9.94542e-06
|
|
|
BHMT
|
[NCBI]
|
9.76155e-06
|
|
|
CBL
|
[NCBI]
|
9.76155e-06
|
|
|
NEFL
|
[NCBI]
|
9.76155e-06
|
|
|
C5
|
[NCBI]
|
9.76155e-06
|
|
|
USH1C
|
[NCBI]
|
9.76155e-06
|
|
|
GDNF
|
[NCBI]
|
9.74349e-06
|
|
|
GCK
|
[NCBI]
|
9.74172e-06
|
|
|
homocystinuria
|
[NCBI]
|
9.64186e-06
|
|
|
SLC6A4
|
[NCBI]
|
9.63203e-06
|
|
|
IRDN
|
[NCBI]
|
9.47304e-06
|
|
|
RETN
|
[NCBI]
|
9.47304e-06
|
|
|
IL9
|
[NCBI]
|
9.47304e-06
|
|
|
MMP12
|
[NCBI]
|
9.47304e-06
|
|
|
GUCY2D
|
[NCBI]
|
9.47304e-06
|
|
|
COL11A2
|
[NCBI]
|
9.47304e-06
|
|
|
TERF2
|
[NCBI]
|
9.47304e-06
|
|
|
PCCB
|
[NCBI]
|
9.47304e-06
|
|
|
ECM1
|
[NCBI]
|
9.47304e-06
|
|
|
CSF1
|
[NCBI]
|
9.2002e-06
|
|
|
SN
|
[NCBI]
|
9.2002e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
9.2002e-06
|
|
|
GALK1
|
[NCBI]
|
9.2002e-06
|
|
|
IGHV
|
[NCBI]
|
9.2002e-06
|
|
|
SFTPB
|
[NCBI]
|
9.2002e-06
|
|
|
HSD11B1
|
[NCBI]
|
9.2002e-06
|
|
|
PTGS2
|
[NCBI]
|
9.16142e-06
|
|
|
BBS
|
[NCBI]
|
9.07946e-06
|
|
|
GH1
|
[NCBI]
|
9.06893e-06
|
|
|
CLN3
|
[NCBI]
|
8.94155e-06
|
|
|
DRD3
|
[NCBI]
|
8.94155e-06
|
|
|
CUBN
|
[NCBI]
|
8.94155e-06
|
|
|
SLC2A1
|
[NCBI]
|
8.94155e-06
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
8.89794e-06
|
|
|
SELP
|
[NCBI]
|
8.69579e-06
|
|
|
GHSR
|
[NCBI]
|
8.69579e-06
|
|
|
DBH
|
[NCBI]
|
8.69579e-06
|
|
|
F12
|
[NCBI]
|
8.69579e-06
|
|
|
SPP1
|
[NCBI]
|
8.61528e-06
|
|
|
MC1R
|
[NCBI]
|
8.53725e-06
|
|
|
AACT
|
[NCBI]
|
8.4618e-06
|
|
|
RHD
|
[NCBI]
|
8.4618e-06
|
|
|
CYP1B1
|
[NCBI]
|
8.4618e-06
|
|
|
BWS
|
[NCBI]
|
8.39983e-06
|
|
|